[#item_full_content]
QUTENZA® Phase III Clinical Trial for Post-Surgical Neuropathic Pain Successfully Enrolls Participants, Thanks to Partnership between Grünenthal and Averitas Pharma November 7, 2024
Localis report urges departments to collaborate in fulfilling government’s flood risk pledges October 11, 2024